Fragrant sesquiterpene isolated from the essential oils of a variety of plants, shrubs and trees. Both isomers occur in nature; the (-)-form is the most widespread and is an active anti-inflammatory component of chamomile. The (+) and (-)-epi isomers are also naturally occurring. Isoln of (-)-form from Matricaria chamomilla: F. Sorm et al., Collect. Czech. Chem. Commun. 16, 626 (1951); of (+)-form from Populus balsamifera: idem et al., Chem. Listy 46, 364 (1952). Synthesis of racemic mixture: L. Ruzicka, M. Liguori, Helv. Chim. Acta 15, 3 (1932); C. D. Gutsche et al., Tetrahedron 24, 859 (1968). Enantioselective synthesis of (-)-form: H. Nemoto et al., Tetrahedron Lett. 34, 4939 (1993). Separation of four stereoisomers: K. Günther et al., Fresenius J. Anal. Chem. 345, 787 (1993). Pharmacology and toxicology of (-)-form: V. Jakovlev, A. von Schlichtegroll, Arzneim.-Forsch. 19, 615 (1969); S. Habersang et al., Planta Med. 37, 115 (1979). Comparative pharmacology of racemate and enantiomers: V. Jakovlev et al., ibid. 35, 125 (1979). Determn by HPLC in chamomile extracts: R. Herrmann, Dtsch. Apoth. Ztg. 36, 1797 (1982); by GC in cosmetic products: D. Andre et al., Int. J. Cosmet. Sci. 13, 137 (1991). Evaluation of use as dermal penetration enhancer: R. Kadir, B. W. Barry, Int. J. Pharm. 70, 87 (1991). Review of anti-inflammatory activity and use in cosmetics: N. Jellinek, Parfums Cosmet. Aromes 57, 55-57 (1984); of absolute configuration studies: G. W. O'Donnell, M. D. Sutherland, Aust. J. Chem. 42, 2021-2034 (1989).
Isoln from Myoporum crassifolium: K. G. O'Brien et al., Aust. J. Chem. 6, 166 (1953).
Isoln from Salvia stenophylla: E. J. Brunke, F. J. Hammerschmidt, Proc. 15th Int. Symp. Essent. Oils Aromat. Plants 1985, 145.
Anti-inflammatory.
Anti-inflammatory (Nonsteroidal)